A.G. Schneiderman Announces $19.5 Million Multi-State Agreement With Bristol-Myers Squibb To End Deceptive Advertising Practices And Off-Label Promotion Of Drug Used To Treat Schizophrenia. (2016, December 6).

Retrieved from https://ag.ny.gov/press-release/ag-schneiderman-announces-195-million-multi-state-agreement-bristol-myers-squibb-end

Aripiprazole. (2016, June 15). Retrieved July 13, 2017, from https://medlineplus.gov/druginfo/meds/a603012.html

Feeley, J., & Fisk, M. C. (2017, April 25). J&J, Bayer accused of hiding Xarelto's dangers, face 18,000 patient lawsuits.

Retrieved from http://www.chicagotribune.com/lifestyles/health/ct-xarelto-internal-bleeding-20170425-story.html

Kluger, N., Jacot, W., Frouin, E., Rigau, V., Poujol, S., Dereure, O., . . . Bessis, D. (2012, May 09). Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: A prospective study of 20 patients | Annals of Oncology | Oxford Academic. Retrieved from https://academic.oup.com/annonc/article/23/11/2879/234091/Permanent-scalp-alopecia-related-to-breast-cancer